Insulin Infusion Pump Market - By Type: Tethered Insulin Pumps, Patch Insulin Pumps (Tubeless); By Application: Type 1 Diabetes, Type 2 Diabetes; By End User: Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centers (ASCs); By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global insulin infusion pump market is experiencing substantial growth, driven by the rising prevalence of diabetes, increasing patient awareness, and advancements in pump technology. Insulin pumps provide precise, continuous insulin delivery and help reduce glycemic variability, making them increasingly preferred over traditional insulin pens and syringes, especially among Type 1 diabetes patients. Technological integration with CGMs (continuous glucose monitors), Bluetooth-enabled mobile apps, and hybrid closed-loop systems is further expanding market acceptance.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
4.3 |
Historical benchmark |
|
2024 |
7.1 |
Five-year CAGR 10.5% |
|
2031 |
14.6 |
Seven-year CAGR 10.7% |
The market is set to more than double by 2031, supported by a growing diabetic population, demand for patient-centric therapies, and increased adoption in emerging markets.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The global insulin infusion pump market is dominated by a few key players, while emerging competitors are introducing wearable and patch pump innovations.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Offerings |
|
Medtronic |
41% |
MiniMed™ series, hybrid closed-loop systems |
|
Insulet Corporation |
23% |
Omnipod® patch pump – tubeless system |
|
Tandem Diabetes Care |
18% |
t:slim X2 pump with Control-IQ™ |
|
Roche Diabetes Care |
8% |
Accu-Chek® Solo and Insight systems |
|
Others (Ypsomed, Sooil, startup innovators) |
10% |
Compact/wearable pumps and regional offerings |
6 | Market Segmentation
By Type:
By Application:
By End User:
By Geography:
7 | Strategic Outlook
Future market growth hinges on device affordability, ecosystem integration (with CGMs and EHRs), and geographic expansion. Players investing in AI-based insulin dosing, sustainable wearables, and DTC (direct-to-consumer) education will likely capture greater market share, especially in Asia-Pacific and Latin America.
Need help?
Chat with our team in a minute.